332 related articles for article (PubMed ID: 17333350)
21. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
22. The role of Kupffer cells in hepatitis B and hepatitis C virus infections.
Boltjes A; Movita D; Boonstra A; Woltman AM
J Hepatol; 2014 Sep; 61(3):660-71. PubMed ID: 24798624
[TBL] [Abstract][Full Text] [Related]
23. Targeting microRNA-122: walking on cutting edge of hepatitis C virus infection therapy.
Motavaf M; Safari S; Alavian SM
Acta Virol; 2014; 58(4):301-8. PubMed ID: 25518710
[TBL] [Abstract][Full Text] [Related]
24. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
Thibault PA; Wilson JA
Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
[TBL] [Abstract][Full Text] [Related]
25. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
26. [The development of therapeutic vaccine for hepatitis C virus].
Kimura K; Kohara M
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1451-7. PubMed ID: 23064054
[TBL] [Abstract][Full Text] [Related]
27. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
Torresi J; Johnson D; Wedemeyer H
J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
[TBL] [Abstract][Full Text] [Related]
28. Current and evolving therapies for hepatitis C.
Moradpour D; Blum HE
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1199-202. PubMed ID: 10563526
[TBL] [Abstract][Full Text] [Related]
29. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
Liu CJ
J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
[TBL] [Abstract][Full Text] [Related]
30. Host and viral features in chronic HCV infection: relevance to interferon responsiveness.
Craxì A; Magrin S; Fabiano C; Linea C; Almasio P
Res Virol; 1995; 146(4):273-8. PubMed ID: 8539489
[TBL] [Abstract][Full Text] [Related]
31. Future therapies for hepatitis C.
Pawlotsky JM; Gish RG
Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
[TBL] [Abstract][Full Text] [Related]
32. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
[TBL] [Abstract][Full Text] [Related]
33. Experimental models for hepatitis C viral infection.
Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
[TBL] [Abstract][Full Text] [Related]
34. Autophagy in hepatitis B or C virus infection: An incubator and a potential therapeutic target.
Zhang L
Life Sci; 2020 Feb; 242():117206. PubMed ID: 31866520
[TBL] [Abstract][Full Text] [Related]
35. Replicative level of hepatitis C virus (HCV) in chronic hepatitis C.
Hayashi N; Kamada T
Intern Med; 1993 Dec; 32(12):944-5. PubMed ID: 8204979
[No Abstract] [Full Text] [Related]
36. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
37. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
38. [Molecular virology of hepatitis C].
Moradpour D; Brass V; Gosert R; Wölk B; Blum HE
Praxis (Bern 1994); 2002 Dec; 91(51-52):2247-53. PubMed ID: 12564041
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis viruses: live and let die.
Herzer K; Sprinzl MF; Galle PR
Liver Int; 2007 Apr; 27(3):293-301. PubMed ID: 17355449
[TBL] [Abstract][Full Text] [Related]
40. Animal models for hepatitis C.
Billerbeck E; de Jong Y; Dorner M; de la Fuente C; Ploss A
Curr Top Microbiol Immunol; 2013; 369():49-86. PubMed ID: 23463197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
